Fact Checked

SurvivorNet Fact Checking and Medical Review Standards:  

The SurvivorNet News Team creates high quality medical information that complies with our industry leading standards for factual accuracy and sourcing from leading experts at academic medical institutions. Every news article is thoroughly fact-checked by our physician collaborators. We vet each piece of work for factual integrity, impartiality, and clearly label any professional conflicts.

All SurvivorNet articles adhere to the following standards:

  1. All studies and research papers cited are from reputable academic medical institutions or peer-reviewed journals.
  2. When we use data, statistics, or quotes these references link to the original source.
  3. All content related to new treatments, drugs, procedures, and so on must clearly describe availability, side effects, treatment target (such as triple negative breast cancer)
  4. All medical information on SurvivorNet is sourced from respected medical professionals with verified medical credentials and links are provided to these sources.
  5. We strive to give the reader relevant background information and include, clearly-sourced contextual health information in all articles. Readers are clearly alerted to any conflicts of interest from a medical source or the authors of a cited study.
/ Updated November 4th, 2020

Could New Non-Hodgkin Lymphoma Drugs Mean Less Chemo in the Future?

NOW
PLAYING
Veteran Told Multiple Myeloma Symptoms Were PTSD
NOW
PLAYING
September is Ovarian Cancer Awareness Month; ‘Exciting’ Advancements in Treating this Cancer Have Been Made in Recent Years
NOW
PLAYING
49ers Linebackers Coach Johnny Holland Has Multiple Myeloma Relapse; Understanding This Rare Blood Cancer
NOW
PLAYING
Glioblastoma Still Lethal Years After Deaths of McCain and Kennedy
NOW
PLAYING
COVID Vaccines Are Far Less Effective in Most Cancer Patients, Ineffective in Some, According to New Research
NOW
PLAYING
Actress Sheetal Sheth Talks Going Public With Her Breast Cancer Diagnosis & Writing a Children's Book Inspired by MeToo

Treatment : Understanding the Options for Diffuse Large B-Cell Lymphoma

SEE MORE   

  • The treatment you get for non-Hodgkin lymphoma will depend on the type of lymphoma, the stage and the how fast it’s growing
  • Diffuse large B-cell lymphoma is the most common type diagnosed in the United States and worldwide
  • People with aggressive non-Hodgkin lymphoma can expect to get a chemotherapy combination called R-CHOP

Treatment : Understanding the Options for Diffuse Large B-Cell Lymphoma

  • The treatment you get for non-Hodgkin lymphoma will depend on the type of lymphoma, the stage and the how fast it’s growing
  • Diffuse large B-cell lymphoma is the most common type diagnosed in the United States and worldwide
  • People with aggressive non-Hodgkin lymphoma can expect to get a chemotherapy combination called R-CHOP

Treatment : Chemotherapy

SEE MORE   

Treatment : Treating Non-Hodgkin Lymphoma in Children

SEE MORE   

Treatment : Treating Non-Hodgkin Lymphoma in Children

  • Children with non-Hodgkin lymphoma are typically given more aggressive chemotherapy because their bodies are generally able to tolerate it better
  • Long-term survival in children with B-cell non-Hodgkin lymphoma is over 90%

Treatment : Mantle Cell Lymphoma

SEE MORE   

  • Mantle cell lymphoma is a type of non-Hodgkin lymphoma
  • The disease can be either slow-growing (indolent) or fast-growing (aggressive)
  • Aggressive mantle cell lymphoma may be treated with a combination of a monoclonal antibody (rituximab) and chemotherapy

Treatment : Mantle Cell Lymphoma

  • Mantle cell lymphoma is a type of non-Hodgkin lymphoma
  • The disease can be either slow-growing (indolent) or fast-growing (aggressive)
  • Aggressive mantle cell lymphoma may be treated with a combination of a monoclonal antibody (rituximab) and chemotherapy
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.